0001824134-26-000001.txt : 20260604 0001824134-26-000001.hdr.sgml : 20260604 20260604141750 ACCESSION NUMBER: 0001824134-26-000001 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20260604 DATE AS OF CHANGE: 20260604 EFFECTIVENESS DATE: 20260604 FILER: COMPANY DATA: COMPANY CONFORMED NAME: BioIntelliSense, Inc. CENTRAL INDEX KEY: 0001824134 ORGANIZATION NAME: EIN: 830671724 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-567652 FILM NUMBER: 261064344 BUSINESS ADDRESS: STREET 1: 17301 W. COLFAX AVENUE STREET 2: SUITE 152 CITY: GOLDEN STATE: CO ZIP: 80401 BUSINESS PHONE: 720-689-9008 MAIL ADDRESS: STREET 1: 17301 W. COLFAX AVENUE STREET 2: SUITE 152 CITY: GOLDEN STATE: CO ZIP: 80401 FORMER COMPANY: FORMER CONFORMED NAME: BioIntellisense, Inc. DATE OF NAME CHANGE: 20200909 D/A 1 primary_doc.xml X0708 D/A LIVE 0001824134 BioIntelliSense, Inc. 17301 W. COLFAX AVENUE SUITE 152 GOLDEN CO COLORADO 80401 720-689-9008 DELAWARE BioIntellisense, Inc. Corporation true David Wang 17301 W. Colfax Ave., Suite 152 Golden CO COLORADO 80401 Executive Officer Director James Mault 17301 W. Colfax Ave., Suite 152 Golden CO COLORADO 80401 Executive Officer Director Conlan Ma 17301 W. Colfax Ave., Suite 152 Golden CO COLORADO 8040180401 Director Xinyaun Yu 17301 W. Colfax Ave., Suite 152 Golden CO COLORADO 80401 Director Other Decline to Disclose 06b true 0001824134-25-000003 2025-12-04 false true true Offering of Preferred Stock and the underlying shares of Common Stock issuable upon conversion of Preferred Stock. false 0 58350027 58349365 662 Includes the issuance of a warrant to purchase preferred stock and the underlying shares of preferred stock upon exercise and the underlying shares of common stock upon conversion. false 14 0 0 0 false BioIntelliSense, Inc. /s/ David Wang David Wang Chief Executive Officer 2026-06-01